Unique ID issued by UMIN | UMIN000039276 |
---|---|
Receipt number | R000044790 |
Scientific Title | Experimental study of the intestinal environment improving effect by intake of lactic acid bacteria producing extract |
Date of disclosure of the study information | 2020/01/28 |
Last modified on | 2020/06/01 16:20:37 |
Experimental study of the intestinal environment improving effect by intake of lactic acid bacteria producing extract
Experimental study of the intestinal environment improving effect by intake of lactic acid bacteria producing extract
Experimental study of the intestinal environment improving effect by intake of lactic acid bacteria producing extract
Experimental study of the intestinal environment improving effect by intake of lactic acid bacteria producing extract
Japan |
Healthy Adults
Not applicable |
Others
NO
Evaluate the intestinal environment improving effect by intake of lactic acid bacteria producing extract for 4 weeks.
Efficacy
Creatinine-corrected urinary indoxyl sulfate levels 4 weeks after continuous intake
Questionnaire(Defection status,
physical condition, etc) 4 weeks after continuous intake
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Intake 10ml of lactic acid bacteria producing extract daily for 4 weeks.
30 | years-old | <= |
50 | years-old | > |
Female
1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Healthy Japanese women who are 30 years old or more and under 50 years old
3.Persons who have constipation tendencies from the preliminary survey questionnaire
4.The top 30 urinary indoxyl sulfate levels at screening
1.Persons who have chronic illness
2.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding
3.Persons who are taking medications that affect the intestinal environment, such as intestinal medicines, laxatives, and antibiotics
4.Persons who are taking dietary fiber or lactic acid bacteria supplements that improve the intestinal environment
5.Persons who are allergic to soy
6.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam
30
1st name | Yasuhiro |
Middle name | |
Last name | Sasuga |
B&S corporation Co., Ltd.
Production & Development Division
102-0073
4-1-28 Kudankita, Chiyoda-ku, Tokyo, JAPAN
03-3288-0115
y-sasuga@bandscorp.jp
1st name | Miho |
Middle name | |
Last name | Matsumoto |
Healthcare Systems Co., Ltd.
Sales Planning Department
105-0004
Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN
050-3640-3595
matsumoto@hc-sys.jp
B&S corporation Co., Ltd.
B&S corporation Co., Ltd.
Self funding
Tokyo Medical and Dental University
Healthcare Systems Co., Ltd.
The Ethics Committee of Healthcare Systems Co., Ltd.
Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN
03-6809-2722
kakehashi@hc-sys.jp
NO
2020 | Year | 01 | Month | 28 | Day |
Unpublished
30
Completed
2020 | Year | 01 | Month | 24 | Day |
2020 | Year | 01 | Month | 24 | Day |
2020 | Year | 02 | Month | 06 | Day |
2020 | Year | 10 | Month | 31 | Day |
2020 | Year | 01 | Month | 28 | Day |
2020 | Year | 06 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044790